Lake Street Maintains Buy on OptimizeRx, Lowers Price Target to $10

Benzinga · 3d ago
Lake Street analyst Eric Martinuzzi maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $11 to $10.